InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Farrow Jeffrey S, 首席财务官. Insider active across 2 companies, notably Global Blood Therapeutics, Inc.. Aggregated, 15 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €182k. Activity tracked since 27 September 2022. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Farrow Jeffrey S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
2,111 股@ US$69.4270.1% 占其流量Common StockSEC:0001405253-26-000007:0
13,042 股Common StockSEC:0001405253-26-000005:0
27,881 股Common StockSEC:0001819790-25-000102:0
1,284 股@ US$46.29100.0% 占其流量Common StockSEC:0001819790-25-000054:0
8,019 股Common StockSEC:0001819790-25-000047:0
27,881 股Common StockSEC:0001819790-24-000089:0
26,739 股Common StockSEC:0000899243-22-033145:0
23,653 股@ US$16.40100.0% 占其流量Common StockSEC:0000899243-22-032265:0
2,763 股Common StockSEC:0000899243-22-030475:0
6,145 股Common StockSEC:0000899243-22-027634:0
2,763 股Common StockSEC:0000899243-22-009239:0
9,020 股Common StockSEC:0000899243-22-004639:0
9,020 股Common StockSEC:0000899243-21-037668:0
2,762 股Common StockSEC:0000899243-21-035221:0
9,020 股Common StockSEC:0000899243-21-031353:0
15 条申报中的 15 条
About Farrow Jeffrey S
Farrow Jeffrey S is Chief Financial Officer. The declarant has 15 filings in total, and in the sampled recent filings from 2021-08-03 to 2026-03-19, the most frequent transaction nature is option exercise, with 0 in buys and 181869 in sells. The companies mentioned are Global Blood Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc.
